USA — A new antibiotic has shown promising results after bypassing several multidrug resistant bacteria in early clinical trials.<br /><br />The trials were conducted on a total of 448 patients with kidney or urinary tract infections, according to a paper published in The Lancet.<br /><br />The antibiotic, cefiderocol, was able to enter the bacteria as it hid among iron molecules.<br /><br />Bacteria in our bodies usually look for iron molecules as our bodies' natural response to an infection is to create a low-iron environment, to stop the bacteria from multiplying.<br /><br />Once cefiderocol is inside the bacteria, it is able to kill it as other antibiotics.<br /><br />However, larger trials would still be needed to ensure the effectiveness of the "trojan horse" antibiotic.
